Has Craig Miller, MD received payments from drug or device companies?

Yes. Drug and device makers reported $261 in general payments to Craig Miller, MD across 10 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Craig Miller, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Craig Miller, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Craig Miller, MD

Ophthalmology · Cambridge, OHNPI 1366709891

Payments from drug & device makers

$261in general payments, 2019–2025

Across 10 payments — averaging $26.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Integra Lifesciences Corporation$127
Shire North American Group Inc$45
Bausch & Lomb, A Division Of Bausch Health US, LLC$42
Novartis$34
AbbVie$13

What the payments were for

Food & beverage$261100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Integra Lifesciences Corporation	1	$127
Shire North American Group Inc	3	$45
Bausch & Lomb, A Division Of Bausch Health US, LLC	3	$42
Novartis	2	$34
AbbVie	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$261 in reported general payments places this provider in the 20th percentile of 640 ophthalmology providers in Ohio.

See all ophthalmology providers in Ohio →

Medicare billing

Part B allowed, 2024

$309,561

Medicare patients

737

Services billed

2,337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RocklatanNetarsudil Mesylat/Latanoprost	53	$26,568
RestasisCyclosporine	28	$23,206
Prednisolone Acetate	881	$20,263
LumiganBimatoprost	32	$12,884
XiidraLifitegrast	15	$11,488
Cyclosporine	21	$9,291
CombiganBrimonidine Tartrate/Timolol	22	$7,528
Ofloxacin	731	$6,500
Latanoprost	810	$5,213
Ketorolac Tromethamine	313	$3,585
Alphagan PBrimonidine Tartrate	17	$3,549
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	230	$3,186
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	13	$2,227
Fluorometholone	24	$1,577
Timolol Maleate	270	$1,528

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieRestasis, Lumigan, Combigan, Alphagan P	$13	$47,16899 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 640 ophthalmology providers in Ohio.

Other ophthalmology in Cambridge

John PajkaLima$17.7M
Justis EhlersCleveland$5M
Lawrence SingermanBeachwood$3.9M
Sunil SrivastavaCleveland$2.8M
Daniel MillerCincinnati$2.3M
Jonathan LassCleveland$1.9M
William WileyCleveland$1.9M
Peter KaiserCleveland$1.5M
David RogersColumbus$1.5M
Michael SnyderCincinnati$1.3M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →